The cerebromicrovasculature: A key player in the pathogenesis of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 4, Issue 3, 2002, Pages 217-223

  Grammas, Paul ^a   Yamada, M ^a   Zlokovic, B ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN BLOOD VESSEL; BRAIN CELL; ENDOTHELIUM CELL; HUMAN; MICROVASCULATURE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW;

EID: 0036592757     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2002-4311     Document Type: Review

References (68)

1. Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease
2. Thrombin accumulation in brains of patients with Alzheimer disease
3. Progression of cerebral amyloid angiopathy: Accumulation of amyloid-β40 in affected vessels
4. An Italian type of HCHWA
5. Neuronal over-expression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid
6. cAMP-dependent protein kinase in cerebral microvessels in aging and Alzheimer's disease
7. Peers Observation of morphological relationships between angiopathic blood vessels and degenerative neuritis in Alzheimer's disease
8. Nitric oxide is elevated in Alzheimer's brain microvessels
9. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV
10. Cerebral amyloid angiopathy in dementia and old age
11. Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin
12. Vascular variant of prion protein cerebral amyloidosis with τ-positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP
13. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy
14. Alzheimer's disease brain microvessels kill neurons in vitro
15. Cerebral microvessels in Alzheimer's have reduced protein kinase ς Activity
16. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease
17. Decreased α-adrenergic receptors at the blood-brain barrier in Alzheimer's disease
18. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy
19. The clinical spectrum of cerebral amyloid angiopathy
20. Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau
21. Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene
22. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study
23. Amyloid-β peptide (1-40) reduction in cerebral blood flow is consequent to RAGE-mediated induction of endothelin-1
24. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly
25. Protein chemical and immunocytochemical studies of meningo-vascular β-amyloid protein in Alzheimer's disease and normal aging
26. Reduced glucose transporter at the blood-brain barrier in cerebral cortex in Alzheimer's disease
27. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type
28. Human blood-brain barrier receptors for Alzheimer's amyloid-β
29. The incidence of cerebral amyloid angiopathy in Alzheimer's disease
30. Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease
31. Advances fuel Alzheimer's conundrum
32. Pathological proteins in senile plaques
33. Ultrastructural studies of amyloid fibrils and senile plaques in human brain
34. High frequency of apolipoprotein E ε2 allele in hemorrhage due to cerebral amyloid angiopathy
35. A Novel APPP mutation (E693G) - The arctic mutation, causing Alzheimer's disease with vascular symptoms
36. Amyloid angiopathy in a Volga German Family with Alzheimer's disease and a praesenilin-2 mutation (N141I)
37. Difference between vascular and plaque core amyloid in Alzheimer's disease
38. Apolipoprotein E ε4 in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease
39. Mechanisms of cell death in primary cortical neurons and PC12 cells
40. Studien zur pathologie der hirgefasse. II. Die drusige entartung der hirnarterien und-capillaren
41. Clearing the brain's amyloid cobwebs
42. Clearance of Alzheimer's amyloid-β(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
43. Amyloid β proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels
44. Fifteen year longitudinal study of blood pressure and dementia
45. Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons
46. Brain infarction and the clinical expression of Alzheimer disease
47. Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease?
48. Apolipoprotein E: High-activity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease
49. High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy
50. Identification of a stable fragment of the Alzheimer amyloid precursor containing the β-protein in brain microvessels
51. Vascular disease risk factors and findings in patients with Alzheimer's disease
52. Truncated apolipoprotein E (ApoE) causes increased intercellular calcium and may mediate ApoE neurotoxicity
53. Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated
54. Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo
55. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: Implications for cerebral amyloid angiopathy
56. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons
57. Senile dementia associated with amyloid β protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-ε4 allele
58. A stop-codon mutation in the BRI gene associated with familial British dementia
59. Cerebral amyloid angiopathy: Incidence and complications in the aging brain. II. The distribution of amyloid vascular changes
60. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy
61. Cerebral amyloid angiopathy: An overview
62. Immune reactions associated with cerebral amyloid angiopathy
63. Vascular variant of Alzheimer's disease characterized by severe plaque-like β protein angiopathy
64. Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly
65. Association of α1-antichymotrypsin polymorphism with cerebral amyloid angiopathy
66. Cerebral amyloid angiopathy in the aged
67. Dementia in cerebral amyloid angiopathy: A clinicopathological study
68. Glycoprotein 330/megalin: Probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer's disease amyloid-β at the blood-brain and blood-cerebrospinal fluid barriers